How We Evaluate GLP-1 Medications

Our review methodology combines three sources of evidence:

• Clinical trial data: Peer-reviewed studies with thousands of participants provide the most reliable efficacy and safety data
• Real-world patient feedback: Aggregated patient reviews and experience reports reveal what daily life on these medications actually looks like
• Clinical experience: Our physician team at Form Blends draws on direct experience prescribing and monitoring GLP-1 therapy for hundreds of patients

We do not accept payment from pharmaceutical companies, and our reviews are not influenced by manufacturer relationships.

Wegovy (Semaglutide 2.4mg) Review

Overview

Wegovy is the weight-loss-specific formulation of semaglutide, manufactured by Novo Nordisk. It was FDA-approved for chronic weight management in June 2021 and has become one of the most prescribed weight loss medications in history.

$1,300-$1,400/mo (brand)

What Patients Say About Wegovy

The most common positive feedback from Wegovy patients:

• "Food noise is gone. I do not think about food all day anymore."
• "I feel full after a few bites. I naturally eat less without feeling deprived."
• "My blood sugar numbers improved dramatically within the first three months."
• "I have more energy than I have had in years."
• "The weekly injection is so easy. I was nervous at first, but it is painless."

The most common complaints:

• "Nausea was rough during the first few weeks of each dose increase."
• "Constipation has been a consistent issue for me."
• "The cost is a barrier. My insurance does not cover it."
• "Weight loss stalled after about 10 months."
• "I lost some muscle along with fat. I wish I had started resistance training sooner."

Our Clinical Assessment

Wegovy remains a top-tier option for weight management in 2026. Its proven cardiovascular benefits set it apart from competitors. The main drawbacks are cost and supply inconsistency. For patients whose insurance covers it or who can access compounded semaglutide through programs like Form Blends, it is an excellent choice.

Zepbound (Tirzepatide) Review

Overview

Zepbound is Eli Lilly's weight management formulation of tirzepatide, a dual GLP-1/GIP receptor agonist. FDA-approved for weight loss in November 2023, it has quickly become one of the most effective weight loss medications available.

$1,000-$1,200/mo (brand)

What Patients Say About Zepbound

Positive feedback:

• "I switched from Wegovy to Zepbound and lost an additional 15 pounds."
• "The appetite suppression is stronger than anything I have tried."
• "My A1C dropped from 6.8 to 5.4. My doctor was amazed."
• "I tolerate Zepbound better than I tolerated Wegovy. Less nausea."
• "The pen design is very user-friendly. No visible needle."

Common complaints:

• "The dose escalation period is longer than semaglutide."
• "I had significant nausea at the 10mg and 15mg doses."
• "Cost is still very high without insurance."
• "Hair thinning has been an issue for me."

Our Clinical Assessment

Zepbound offers the highest average weight loss of any currently available medication. Its dual-agonist mechanism gives it an edge over single-receptor GLP-1 drugs. For patients seeking maximum weight loss, Zepbound is the leading option in 2026. The longer dose escalation period requires patience but is worth it for the superior results. GLP-1 vs alternatives

Ozempic (Semaglutide 1.0mg/2.0mg) Review

Overview

Ozempic is the diabetes formulation of semaglutide. While not FDA-approved for weight loss, it is frequently prescribed off-label for weight management. Its maximum dose (2.0mg) is lower than Wegovy's maintenance dose (2.4mg).

$900-$1,000/mo (brand)

Our Clinical Assessment

Ozempic is a reasonable option for patients with type 2 diabetes who also want weight loss, or for those whose insurance covers diabetes medications but not weight loss drugs. However, for patients primarily seeking weight loss, Wegovy (at the higher 2.4mg dose) or Zepbound will produce better results.

Mounjaro (Tirzepatide) Review

Overview

Mounjaro is the diabetes formulation of tirzepatide. Like Ozempic, it is sometimes prescribed off-label for weight loss. It uses the same medication and dose range as Zepbound.

$1,000-$1,200/mo (brand)

Saxenda (Liraglutide 3.0mg) Review

Overview

Saxenda is an older GLP-1 medication that requires daily injections. It produces more modest weight loss than newer weekly options.

Contact provider for current pricing

Our Clinical Assessment

Saxenda has largely been surpassed by newer, more effective options. The need for daily injections and lower efficacy make it a less attractive choice in 2026. We generally recommend weekly semaglutide or tirzepatide over Saxenda for most patients.

Compounded GLP-1 Medications Review

Overview

Compounded semaglutide and tirzepatide are prepared by licensed compounding pharmacies and are available at significantly lower cost than brand-name versions. These medications use the same active ingredient but are not manufactured by the original pharmaceutical companies.

Our Clinical Assessment

Compounded GLP-1 medications offer a legitimate, more affordable path to treatment for patients who cannot afford or access brand-name versions. The key is working with a reputable provider who sources from accredited compounding pharmacies with proper quality controls. At Form Blends, we use only licensed, quality-verified compounding partners.

Head-to-Head Comparison: All GLP-1 Medications in 2026

How to Choose Between GLP-1 Medications: A Decision Framework

With multiple GLP-1 options available, selecting the right one can feel overwhelming. Here is a practical framework based on different patient priorities:

If Maximum Weight Loss Is Your Top Priority

Choose Zepbound (tirzepatide). Clinical data consistently shows the highest average weight loss (20-22%) among available GLP-1 medications. The dual GLP-1/GIP mechanism provides an edge over single-receptor drugs. If tirzepatide is not available or tolerated, Wegovy (semaglutide) is the next best option at 15-17% average weight loss.

If Cardiovascular Protection Is Important

Choose Wegovy (semaglutide). It is the only weight loss medication with proven cardiovascular outcomes data from the SELECT trial, showing a 20% reduction in major cardiovascular events. This makes it the clear choice for patients with cardiovascular risk factors or a family history of heart disease.

If Cost Is Your Primary Concern

Consider compounded semaglutide through a reputable provider like Form Blends. At $300-$600 per month, compounded formulations offer the same active ingredient at a fraction of brand-name prices. If you have insurance that covers GLP-1 medications, the brand-name version covered by your plan will typically be the most cost-effective option.

If You Have Type 2 Diabetes

Both Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for diabetes. Insurance coverage tends to be better for diabetes-indicated medications. Mounjaro has shown the strongest HbA1c reductions in head-to-head comparisons. GLP-1 for type 2 diabetes

If Side Effect Tolerance Is a Concern

All GLP-1 medications have similar side effect profiles, but individual tolerance varies. If you have had significant GI side effects on one medication, switching to a different one sometimes helps. Some patients tolerate tirzepatide better than semaglutide, or vice versa. Your physician can guide this decision based on your experience.

Evaluating Telehealth GLP-1 Providers: What to Look For

With the surge in GLP-1 demand, numerous telehealth companies have entered the market. Quality varies significantly. Here is what separates good providers from the rest:

At Form Blends, we meet all of the quality indicators above. Our program is physician-supervised from start to finish, with transparent pricing, accredited pharmacy partners, and comprehensive support throughout your treatment.

What Real Patients Wish They Had Known

Based on feedback from hundreds of patients, here are the most common things people wish they had known before starting GLP-1 therapy:

• "Start resistance training from day one." Muscle loss is a real concern. Patients who started lifting weights early in their treatment had better body composition outcomes.
• "Prioritize protein above all else." Many patients did not realize how important protein was until they noticed muscle loss or fatigue.
• "The first month is not representative." Do not judge the medication by your first few weeks at the lowest dose. Real results come after reaching the maintenance dose.
• "Nausea is manageable." Most patients found that nausea was their biggest fear but turned out to be temporary and manageable with dietary adjustments.
• "It changes your relationship with food in a good way." Many patients describe a fundamental shift in how they think about and interact with food.
• "Plan for the financial commitment." GLP-1 therapy is an ongoing expense. Understanding the costs upfront helps avoid surprises.
• "Hydration matters more than you think." Dehydration makes side effects worse and can stall weight loss.

The Patient Experience: Month by Month

Reviews are most useful when they capture the full treatment arc, not just a snapshot. Here is what patients typically report at each phase of GLP-1 therapy, based on aggregated feedback and clinical experience:

Month 1: Adjustment

Most patients report mild effects at the starting dose. Appetite suppression is subtle. Nausea may be present but manageable. Weight loss is modest (2-5 pounds). The dominant sentiment is cautious optimism mixed with uncertainty about whether the medication is "working." Patients who set appropriate expectations for this phase are more satisfied than those who expect immediate dramatic results.

Months 2-3: Building Momentum

This is when most patients begin to feel confident the medication is working. Appetite suppression becomes more pronounced with dose increases. Weight loss accelerates to 1-2 pounds per week. Patients report noticing changes in how their clothes fit. Side effects may intensify briefly with each dose increase but generally remain manageable. Satisfaction ratings climb significantly during this phase.

Months 4-6: Peak Engagement

Patients are at or approaching the maintenance dose. Weight loss is consistent and visible. Friends and family begin commenting. Lab values are improving. Energy levels are higher. This is typically the period of highest patient satisfaction. Many patients describe feeling "in the zone" where healthy habits feel natural and results are reinforcing.

Months 7-12: Steady Progress

Weight loss continues but the rate gradually slows. This is normal but can be psychologically challenging for patients who have become accustomed to rapid progress. Body composition changes may continue even when the scale plateaus. Patients who track measurements, photos, and health markers in addition to weight tend to maintain higher satisfaction during this phase.

Months 12-18: Maintenance Phase

Weight stabilizes near its new set point. The focus shifts from active weight loss to weight maintenance. Some patients report decreased motivation as the novelty of results fades. However, patients who have built sustainable habits and who continue to see their physician regularly maintain the best long-term outcomes. Satisfaction remains high for patients who view GLP-1 therapy as an ongoing health management tool rather than a temporary intervention. GLP-1 weight loss timeline

What Patients Wish They Had Known Before Starting

Across thousands of reviews, several themes emerge when patients reflect on what they wish they had known at the beginning of their GLP-1 journey. The most common responses include the following.

First, many patients say they wish they had started sooner. Fear of injections, stigma around weight loss medication, or hope that willpower alone would work kept them from seeking treatment for years. In retrospect, most patients view the delay as lost time.

Second, patients consistently report that the side effects were more manageable than they expected. Online forums tend to amplify negative experiences, creating a distorted picture. Most patients experience mild nausea in the first few weeks that resolves with simple management strategies.

Third, many patients wish they had understood the importance of protein intake from the beginning. Inadequate protein during rapid weight loss leads to muscle loss, fatigue, hair thinning, and a slower metabolism. Patients who prioritized protein from day one had better body composition outcomes and fewer side effects. GLP-1 diet plan

Fourth, patients frequently mention that they underestimated the emotional component of weight loss. Changing your relationship with food, adjusting your self-image, and navigating comments from others all require psychological energy that many patients did not anticipate.

Finally, patients wish they had taken better "before" measurements. Not just weight, but waist circumference, hip circumference, blood pressure, fasting glucose, cholesterol panel, and detailed photographs. Having comprehensive baseline data makes progress far more visible and motivating during plateaus. GLP-1 before and after results

How to Use Reviews Wisely

Patient reviews are a valuable resource, but they require critical reading. Keep in mind that people who have extreme experiences (very positive or very negative) are more likely to leave reviews than those with moderate, steady results. This creates a skewed picture that may not reflect the typical patient experience. When reading reviews, pay attention to the reviewer's starting point (BMI, health conditions, age) and how closely it matches your own profile. A review from someone with a similar starting point and health history will be far more relevant to your expected outcomes than a review from someone in a completely different situation. Our team at Form Blends can help you set realistic expectations based on clinical data rather than anecdotal reviews alone.

Frequently Asked Questions About GLP-1 Reviews

Which GLP-1 medication has the best reviews in 2026?

Zepbound (tirzepatide) has the highest effectiveness ratings, while Wegovy (semaglutide) has the strongest overall safety and cardiovascular evidence. Both receive excellent patient reviews. The best choice depends on your individual health profile and goals. GLP-1 vs alternatives

Are compounded GLP-1 medications as good as brand-name versions?

When sourced from accredited compounding pharmacies, compounded GLP-1 medications contain the same active ingredient and can produce comparable results. Quality varies by pharmacy, so it is important to work with a provider like Form Blends that vets its pharmacy partners carefully.

What percentage of patients are satisfied with GLP-1 medication?

Patient satisfaction surveys consistently show rates above 80% for semaglutide and tirzepatide. The most common reasons for dissatisfaction are cost, side effects that do not improve, and insufficient weight loss (usually in patients who did not reach maintenance dose).

Do GLP-1 reviews differ between men and women?

Overall satisfaction is similar between genders. Men tend to report slightly faster initial weight loss, while women more frequently report hormonal side effects and weight fluctuations related to menstrual cycles. Both genders achieve significant weight loss on GLP-1 therapy. GLP-1 for women GLP-1 for men

What is the most common reason people stop taking GLP-1 medication?

Cost is the number one reason patients discontinue GLP-1 therapy, followed by persistent side effects and, less commonly, insufficient weight loss. Working with a provider who offers affordable options and proactive side effect management can help address the first two reasons.

Are there any new GLP-1 medications expected in 2026?

Several new medications are in late-stage development, including oral semaglutide at higher doses for weight loss, CagriSema (semaglutide plus cagrilintide), and retatrutide (a triple agonist). These are expected to offer even greater efficacy and more convenient dosing options.

How do telehealth GLP-1 programs compare?

Telehealth GLP-1 programs vary significantly in quality. Key factors to evaluate include physician qualifications, ongoing monitoring and follow-up, pharmacy quality, and comprehensiveness of the treatment plan (medication only vs. medication plus lifestyle support). At Form Blends, our program includes physician supervision, personalized treatment plans, dietary guidance, and regular check-ins.

Should I read online patient reviews before starting GLP-1 therapy?

Patient reviews can be helpful for understanding the day-to-day experience, but remember that online reviews skew toward extremes (very positive or very negative). Clinical trial data provides a more accurate picture of what the average patient can expect. Our physicians at Form Blends can help you set realistic expectations based on your specific health profile.

Get Expert Guidance on GLP-1 Therapy

Reading reviews is a great first step, but the best way to determine which GLP-1 medication is right for you is to consult with a physician who specializes in weight management. Our team at Form Blends evaluates your complete health picture and recommends the optimal treatment approach.

Schedule your consultation today.

Get started with Form Blends